RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Bisanzio, D., Estofolete, C. F., & Reithinger, R. (2024). Dengue and diabetes comorbidity: an emerging public health threat. International Health. Advance online publication. https://doi.org/10.1093/inthealth/ihae089
Dengue is of growing global public health concern. Diabetes is a significant risk factor for severe dengue and dengue-related mortality. Countries with the highest number of reported dengue cases are projected to experience a substantial increase in diabetes by 2050. This likely will result in an increased incidence of dengue-diabetes comorbidity, and, hence, in severe dengue and dengue-related mortality. Countries that are or will be affected by a high burden for both diabetes and dengue should urgently design strategies to minimize the health and economic impact that a diabetes-dengue comorbidity could have on affected populations.